Informations générales (source: ClinicalTrials.gov)
A Prospective Non-interventional Study Documenting the Management and Outcomes of Adult Patients With Acute Myeloid Leukemia (AML) (ALFAPPP)
Observational [Patient Registry]
Acute Leukemia French Association (Voir sur ClinicalTrials)
avril 2022
avril 2046
29 juin 2024
During the last fifteen years, the landscape of AML diagnosis and therapeutical options
has markedly evolved. Refined genetic and prognostic characterizations, together with new
drug approvals and new allogeneic hematopoietic stem cell transplantation (HSCT)
procedures, have increased patient journey diversity.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CLCC INSTITUT GUSTAVE ROUSSY | Jean-Baptiste MICOL | 20/06/2024 12:17:03 | Contacter | ||
HOPITAL NOVO | VAIDA | 14/02/2025 09:03:12 | Contacter | ||
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
AP-HP - Hôpital Avicenne | Thorsten BRAUN, MD-Prof | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Necker-Enfants Malades | Ambroise MARCAIS, MD | Contact (sur clinicalTrials) | |||
AP-HP - Hôpital Saint Antoine | Ollivier LEGRAND, MD-Prof | Contact (sur clinicalTrials) | |||
CENTRE HOSPITALIER SUD FRANCILIEN | Stéphanie HAIAT, MD | Contact (sur clinicalTrials) | |||
CH DE VERSAILLES SITE ANDRE MIGNOT | Juliette LAMBERT, MD | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
C H U DE LIMOGES- Hopital Dupuytren - Limoges - France | Pascal TURLURE, MD | Contact (sur clinicalTrials) | |||
Centre Antoine Lacassagne - Nice - France | Anna BORRA, MD | Contact (sur clinicalTrials) | |||
Centre Henri Becquerel - Rouen - France | Emilie LEMASLE, MD | Contact (sur clinicalTrials) | |||
Centre Hopsitalier de l'Est Francilien - Site de Meaux - Meaux - France | Jamilé FRAYFER, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier de Dunkerque - Dunkerque - France | Kevin James WATTEBLED, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier de Roubaix - Roubaix - France | Isabelle PLANTIER, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier de St Quentin - Saint-Quentin - France | Reda GARIDI, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier Dr Schaffner - Lens - France | Claire BORIES, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier Lyon Sud - Pierre-Bénite - France | Maël HEIBLIG, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier Valenciennes - Valenciennes - France | Sabine TRICOT, MD | Contact (sur clinicalTrials) | |||
Centre Hospitalier Victor Dupouy - Argenteuil - France | Ahmad AL JIJAKLI, MD | Contact (sur clinicalTrials) | |||
CHRU de Lille- Hopital C. HURIEZ - Lille - France | Céline BERTHON, MD | Contact (sur clinicalTrials) | |||
Chu Amiens - Amiens - France | Delphine LEBON, MD | Contact (sur clinicalTrials) | |||
CHU de la cote de Nacre - Caen - France | Sylvain CHANTEPIE, MD | Contact (sur clinicalTrials) | |||
CHU Dijon- François Mitterrand - 21000 - Dijon - France | Contact (sur clinicalTrials) | ||||
CHU La Conception - Marseille - France | Laure FARNAULT, MD | Contact (sur clinicalTrials) | |||
CHU Nice,Hopital Archet 1 - Nice - France | Thomas CLUZEAU, MD-Prof | Contact (sur clinicalTrials) | |||
GHICL-Hopital St Vincent de Paul - Lille - France | Benjamin CARPENTIER, MD | Contact (sur clinicalTrials) | |||
Hôpital Henri Mondor AP-HP - Créteil - France | Cécile PAUTAS, MD | Contact (sur clinicalTrials) | |||
Hôpital MILITAIRE PERCY - Clamart - France | Jean-Valère MALFUSON, MD-Prof | Contact (sur clinicalTrials) | |||
Hopital Pitié-Salpétrière APHP - Paris - France | Madalina UZUNOV, MD | Contact (sur clinicalTrials) | |||
Hôpital Saint Louis- APHP - Paris - France | Raphaël ITZYKSON, MD-Prof | Contact (sur clinicalTrials) | |||
Institut Curie - Hôpital René HUGUENIN - Saint-Cloud - France | Jacques VARGAFTIG, MD | Contact (sur clinicalTrials) | |||
Institut Gustave Roussy - Villejuif - France | Jean-Baptiste MICOL, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patient aged 18 years old or more
- Patient with newly diagnosed previously untreated de novo, secondary or
therapy-related AML
- Patients with R/R de novo, secondary or therapy-related AML
- Patient with Health insurance
- Patient aged 18 years old or more
- Patient with newly diagnosed previously untreated de novo, secondary or
therapy-related AML
- Patients with R/R de novo, secondary or therapy-related AML
- Patient with Health insurance
- Acute promyelocytic leukemia
- AML which is not morphologically proven (patients with granulocytic sarcoma may be
included)
- For newly diagnosed AML: previous treatment of leukemia apart from hydroxyurea.
Previous anti leukemia treatments are allowed if they were administered before the
diagnosis of AML to treat a MDS, MPN, MPN/MDS or CML
- Opposition of the patient to participate to this non-interventional study
More specific eligibility criteria might be requested to enter some study modules